Onconova Announces Results of Interim Analysis of Metastatic Pancreatic …
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic …
17, 2013 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the discontinuation of the Phase 3 ONTRAC study of …
Read more on Wall Street Journal
Dual Diagnosis Treatment Center Testimonial – Alli’s Story — http://www.sovcal.com/dual-diagnosis-treatment.shtml Alli talks about how she was referred to Sovereign Health of California Dual Diagnosis treatment center …
More Dual Diagnosis Treatment Centers Information…